The future of bronchiectasis management

Symposium
Chairs: E. Polverino (Barcelona, Spain), G. Rohde (Frankfurt am Main, Germany)
Aims: To describe the effects of early life, including demographic, inflammatory and genetic factors, on the development of bronchiectasis; to review recent randomised studies and observational data that are leading to improvements in the management of bronchiectasis; to describe current options for the management of Pseudomonas aeruginosa pulmonary infections in patients with bronchiectasis; and to describe possible future treatments for bronchiectasis in adults.
Mucus and microbes: why does bronchiectasis develop?
K. Ramsey (Bern, Switzerland)
WebcastSlide presentation
WebcastSlide presentation
State of the art management of bronchiectasis
A. O'Donnell (Washington, United States of America)
WebcastSlide presentation
WebcastSlide presentation
Management of chronic airway infection in bronchiectasis
J. Chalmers (Dundee (Angus), United Kingdom)
WebcastSlide presentation
WebcastSlide presentation
Where do we go from here? Future directions, endpoints and approaches
F. Blasi (Milan, Italy)
WebcastSlide presentation
WebcastSlide presentation